Evidence Analysis

It is a challenge for health plans and clinicians to distill and analyze volumes of clinical evidence to determine likely clinical, financial, and risk impacts. This is what we do.

Accessed through the Hayes Knowledge Center, the Evidence Analysis Solution addresses the following fundamental questions to help our clients determine coverage positions:

  • Does the technology improve health outcomes?
  • Are there other benefits associated with the technology?
  • What harms might be associated with the technology?
  • Have patient selection criteria been established for the technology?
  • For which patients might the technology provide a benefit?

Topical Oxygen Therapy for Chronic Wound Healing

Health Problem: Chronic wounds are those that fail to heal with at least 30 days of optimized standard wound therapy, which usually includes cleaning, debridement, infection control, dressing, and offloading. Poor circulation is a common cause across etiologies, including diabetes. Chronic foot ulcers in people with diabetes may occur when foot injuries, such as cuts, blisters…

Functional Electrical Stimulation for Rehabilitation Following Spinal Cord Injury

Health Problem: Spinal cord injury (SCI) is typically the result of trauma. Automobile accidents are the most common cause, with falls and violence (primarily gunshot wounds) next in frequency. Various studies of the prevalence of SCI in the United States for the year 2016 have reported estimates between 243,000 and 347,000 persons. Although SCI used to occur primarily in youn…

UroLift System (NeoTract Inc.) for Treatment of Benign Prostatic Hyperplasia

Health Problem: Benign prostatic hyperplasia (BPH) is an enlargement or growth of the prostate that affects approximately 8 million men in the United States, including 30% of men older than 50 years of age and nearly 70% of men older than 70 years of age. The enlarged prostate restricts the urethra and applies pressure on the base of the blad…

Comparative Effectiveness of Bioresorbable Vascular Scaffold Stents Versus Other Drug-Eluting Stents for the Treatment of Coronary Artery Disease

Health Problem: Coronary artery disease (CAD) is the most common type of heart disease and the leading cause of death in both men and women in the United States. CAD occurs when the supply of oxygen-rich blood to the heart is limited. Plaque buildup in the coronary arteries, otherwise known as atherosclerosis, develops over many years, hardening and narrowing the artery, thus …

Ketamine as an Adjunct to Electroconvulsive Therapy for Treatment-Resistant Depression

Health Problem: Estimates suggest that 4 million Americans suffer from severe treatment-resistant depression (TRD) that is refractory to multiple therapies. TRD is typically defined as depression that does not respond to at least 2 attempts at treatment of adequate duration with appropriate doses of antidepressants, but there is no official consensus definition.

Intravenous Immunoglobulin for Treatment of Intractable Epilepsy in Pediatric Patients

Health Problem: Intractable epilepsy is diagnosed in 5% to 20% of pediatric patients with new-onset epilepsy. If uncontrolled, seizures in childhood may have a detrimental or even catastrophic impact on the developing brain. A connection has been made between inflammatory processes and neurological disease, including epilepsy, which may present new therapeutic approaches.

Comparative Effectiveness Review of Hyaluronic Acid for Knee Osteoarthritis: A Review of Reviews

Health Problem: Osteoarthritis (OA) is a painful condition in which the cartilage between the bones degenerates, no longer providing a smooth, gliding surface for motion or adequate cushioning. Because OA damages the cartilage and may ultimately damage the bone, it disrupts how components work together, resulting in pain, swelling, inflammation, muscle weakness, impaired quali…